Specific antibodies against the KCC2a and KCC2b isoforms.
A, whole-brain lysates obtained from P2 mice were analyzed by
standard SDS-PAGE and immunoblotting (IB) with affinity-purified
KCC2a antiserum (see “Experimental Procedures”). The KCC2a
antiserum (diluted 1: 2000) detects a major product of ∼140 kDa
(arrowhead, corresponding to KCC2a monomer), and occasionally
(cf. B), a minor band of ∼200 kDa. A similar, higher molecular
mass band observed with other KCC2 antibodies was suggested to represent the
interaction of KCC2 with other proteins
(28). These bands are not
observed when the antiserum is preadsorbed with 1 μg/ml immunizing peptide.
As a control, the membrane was reblotted with an antibody against GAPDH.
B, whole-brain lysates of embryonic day 17.5 (E17) wild-type (WT)
mice and their KCC2 null mutant (KO) littermates were analyzed as
above. The KCC2a antiserum detected the expected product of ∼140 kDa from
the WT but not from the KO lysate. C, lysates of HEK293 cells,
transiently transfected with KCC2a or KCC2b expression plasmids, were analyzed
as above with KCC2a, KCC2b, or KCC2pan antibodies (see “Experimental
Procedures”). The KCC2a antiserum detected a product of ∼140 kDa
from lysates of HEK293 cells transfected with the KCC2a plasmid but not with
the KCC2b expression vector. Similarly, the KCC2b antiserum stained a product
of ∼140 kDa from lysates of KCC2b-expressing but not KCC2a-expressing
cells. The KCC2b antibody was raised against a 15-amino-acid peptide
corresponding to the N terminus of the KCC2b isoform
(11). Because the last five
amino acids in the peptide are common to both KCC2 isoforms, the specificity
of the antibody for the KCC2b isoform is notable.